Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Italy
    2026 VAC US SMFM Maternal RSV QI
    Release Date:
    Partner: Society for Maternal Fetal Medicine
    Review Process: Expert Review Panel
    Quality Improvement Vaccines USA
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Expert Review Panel
    Education Oncology All
    Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting Professorship
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology USA
    New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom
    Guideline Concordant Care and New Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enhancing HCPs’ Preparedness: Maternal Immunization Knowledge Updates
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Internal Medicine Japan
    Interventional Research Studies with Elranatamab
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Research in Ulcerative Colitis (UC) 2024
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey
    Advances in the Management of Ulcerative Colitis (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Research in Ulcerative Colitis (UC) 2024
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Oncology Japan
    Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
    Release Date:
    Partner: Sumitomo Pharma
    Review Process: Pfizer Internal
    Education Oncology USA